Population-based pharmaceutical sector productivity measurement: The determinants of prescription drug utilization and expenditures.

Project number: 
03-007a
Approval date: 
Wednesday, September 10, 2003
Principal Investigator: 
Morgan,Steve
Institution: 
Not Available
Funding Agency: 
Canadian Institutes of Health Research(CIHR)
Datasets requested: 
Not available
Research objective: 
Publications: 

Journal Publication

  • Raymond, C.; Morgan, S.; Katz, A.; Kozyrskyj, A. (2007) "A populatioin-based analysis of statin utilization in British Columbia." Clinical Therapeutics 29(9): 2107-19
  • Raymond, C.; Caetano, P.; Morgan, S. (2007) "Antidepressant utilization in British Columbia." Psychiatric Services 58(1): 79-84
  • Morgan, S.G. (2006) "Prescription drug expenditures and population demographics." Health Services Research 41(2): 411-428
  • Mintzes, B.; Morgan, S.; Bassett, K. (2005) "Medicine by media: Did a critical television documentary affect prescribing of cyprotone-estradiol (Diance-35)?" Canadian Medical Assocation Journal 173(11): 1313-1315
  • Morgan, S.G. (2005) "Booming prescription drug expenditure: A population-based analysis of age dynamics." Medical Care 43(10): 996-1008
  • Morgan, S.; Bassett, K.; Barer, M.; Evans, R.; Wright, J.; Black, C. (2005) "Are breakthough drugs driving pharmaceutical expenditures? Evidence from Canada." British Medical Journal 331(7520); 815-816
  • Morgan, S.G.; Barer, M.L.; Agnew, "Seniors’ prescription drug cost inflation and cost containment: Evidence from British Columbia." Health Policy (2004) 68 3 299-307

Presentation of research material (poster/seminar/lecture etc.)

  • Morgan, S. "The use of data for pharmaceutical policy research." Keynote Speech, (2008) Data Users Conference, hosted by the Canadian Institute for Health Information and Statistics Canada, Ottawa, September 2008
  • Morgan, S. "Pharmaceutical cost crisis: causes, consequences, cures." 2007 Labelle Lecture McMaster University, Hamilton, October 2007
  • Morgan, S. "Equity in access to medicines in Canada: Diagnoses and prescriptions. How soon is now?" Health Care for Every Generation, Conference hosted by the Canadian Federation of Nurses Unions, Moncton, August 2007
  • Morgan, S. "Data for analysing pharmaceuticals and pharmaceutical policy." Data Users’ Conference 2006, hosted by the Canadian Institute for Health Information (CIHI) and Statistics Canada, Vancouver, September 2006
  • Morgan, S. "Implications of population aging on pharmaceutical policy for BC." Premier's Council on Aging and Seniors' Issues, Vancouver, March 2006
  • Morgan, S. "Expenditure overdose: the causes and consequences of rising prescription drug expenditures." Annual General Meeting, Friends of Medicare, Calgary, June 2005
  • Morgan, S. "Measuring ‘quality,’ ‘accessibility.’ and ‘sustainability’ – Are drugs part of the problem or part of the solution?” Tools For Advancing Pharmaceuticals Management." Canadian Coordinating Office for Health Technology Assessment; Canadian Institute for Health Information; Health Canada, Therapeutic Products Directorate; and the Patented Medicine Prices Review Board, Ottawa, November 2004

Conference abstract/presentation

  • Morgan, S. "Drug expenditures in Canada: A population-based analysis of trends and causes." Annual Research Meeting of Academy Health, San Diego, June 2004

Report

  • Morgan, S.G.; Schaub, P.; Mooney, D. et al (2005) "The British Columbia Rx Atlas." Vancouver: UBC Centre for Health Services and Policy Research

Page last revised: December 5, 2017